Saturday, July 11, 2026

pharma · Pterygium · Open Angle Glaucoma

Zhongshan Ophthalmic Center

Zhongshan Ophthalmic Center clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Guangzhou, CN HQ
85 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Guangzhou, CN
Employees
85
Programs
2
Drugs
5
Patents
0
Intelligence · Clinical Programs

Zhongshan Ophthalmic Center projects

2 ClinicalTrials.gov programs sponsored by Zhongshan Ophthalmic Center.

Zhongshan Ophthalmic Center has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 0.1% bromfenac

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    Pterygium

    approved small molecule completed

    1 trial
  2. Routine IOP-lowering medications

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    Open Angle Glaucoma

    small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Zhongshan Ophthalmic Center have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.